SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences informs about outcome of board meeting

11 Nov 2022 Evaluate
Zydus Lifesciences has informed that the Board of Directors at their meeting held today, November 11, 2022, based on the recommendations of Audit Committee, approved the Unaudited Financial Results for the quarter / half year ended on September 30, 2022. In this regard, the company enclosed the following: the Unaudited Financial Results (standalone and consolidated) for the quarter / half year ended on September 30, 2022, reviewed by the Audit Committee and taken on record by the Board of Directors pursuant to regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations); the Limited Review Reports of Deloitte Haskins & Sells LLP, Chartered Accountants and the Statutory Auditors of the Company certifying the limited review of the Unaudited Financial Results (standalone and consolidated) of the Company for the quarter / half year ended on September 30, 2022 pursuant to regulation 33 of the Listing Regulations; press release proposed to be published in the newspapers in the matter of Unaudited Financial Results for the quarter / half year ended on September 30, 2022.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

937.30 -5.25 (-0.56%)
20-Apr-2026 14:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.20
Dr. Reddys Lab 1233.60
Cipla 1232.55
Zydus Lifesciences 937.30
Lupin 2326.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×